Latest Breaking News On - Ligand pelican expression technology - Page 2 : comparemela.com

Ligand Provides Highlights from its Investor and Analyst Day Event

Ligand Provides Highlights from its Investor and Analyst Day Event
pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesSimon latimerBruce vossVerona ensifentrineNovan berdazimerTravere sparsentanGilead sciencesLigand pharmaceuticalsLigand pharmaceuticals incorporatedBaxter internationalExchange commissionPelican expression technologyLigand pelican expression technologyExecutive management reviewed business modelGrowth drivers following

Ligand Announces Completion of - GuruFocus com

GuruFocus Article or News written by Business Wire and the topic is about:

United statesSunil patelJennifer cochranMatt korenbergMatt foehrAcrotech biopharmaWillkie farr gallagherLas vegasSarah boyceBristol myers squibbJohn higginsTavo espinozaAndrew reardonOctavio tavo espinozaGilead sciencesLigand pharmaceuticals

Ligand to Report Third Quarter Financial Results on November 7

Ligand to Report Third Quarter Financial Results on November 7
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

John higginsSimon latimerBruce vossMatt korenbergTavo espinozaGilead sciencesLigand pharmaceuticalsBaxter internationalLigand pharmaceuticals incorporatedLigand pelican expression technologyWall streetPharmaceuticals incorporatedPelican expression technology

Ligand Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

EMERYVILLE, Calif. (BUSINESS WIRE) #earnings Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today announced that on October 3, 2022, the Human Capital Management and Compensation Committee of Ligand’s Board of Directors granted non-qualified stock option awards to purchase an aggregate of 10,770 shares of its.

Simon latimerBruce vossGilead sciencesLigand pharmaceuticalsBaxter internationalLigand pharmaceuticals incorporatedCompensation committee of ligand board directorsLigand pelican expression technologyHuman capital managementCompensation committeeInducement planNasdaq listing ruleNasdaq global select marketPelican expression technology

Ligand Announces Record Date and Details for Distribution for OmniAb Spin-Off

Ligand Pharmaceuticals Incorporated today announced that its board of directors has set October 26, 2022 as the record date for the dividend of shares of common stock of OmniAb, Inc. to be. | October 3, 2022

New yorkUnited statesBaxter internationalOmniab inc newAvista acquisition corpOmniab incAvista public acquisition corpGilead sciencesLigand pharmaceuticalsLigand pharmaceuticals incorporatedExchange ratioExchange commissionEarnout exchange ratioAvista capital holdingsLigand pelican expression technologyRecord date